<unk>  is a bisphosphonate that is FDA approved for the treatment of osteoporosis in postmenopausal women, glucocorticoid-induced osteoporosis, paget's disease of bone, to increase bone mass in men with osteoporosis.   Common adverse reactions include abdominal pain, acid regurgitation, constipation, diarrhea, dyspepsia, musculoskeletal pain, nausea.
Alendronate
Zoledronic acid
Risedronate
Tiludronate
Denosumab
Zoledronate
Etidronate
Pamidronic acid